Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response.

Hiratsuka I, Itoh M, Yamada H, Yamamoto K, Tomatsu E, Makino M, Hashimoto S, Suzuki A.

Endocr J. 2015;62(12):1059-66. doi: 10.1507/endocrj.EJ15-0448. Epub 2015 Sep 20.

2.

Circulating chemokines in patients with autoimmune thyroid diseases.

Domberg J, Liu C, Papewalis C, Pfleger C, Xu K, Willenberg HS, Hermsen D, Scherbaum WA, Schloot NC, Schott M.

Horm Metab Res. 2008 Jun;40(6):416-21. doi: 10.1055/s-2008-1073151. Epub 2008 Apr 14. Erratum in: Horm Metab Res. 2008 Jun;40(6):433. Chao, L [corrected to Liu, C].

PMID:
18415893
3.

Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.

Song RH, Yu ZY, Qin Q, Wang X, Muhali FS, Shi LF, Jiang WJ, Xiao L, Li DF, Zhang JA.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4024-31. eCollection 2014.

4.

Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases.

Cakir M, Levendoglu F, Kiyici A, Coskun Y.

Autoimmunity. 2011 Sep;44(6):496-503. doi: 10.3109/08916934.2011.561818. Epub 2011 Apr 4.

PMID:
21457060
5.

25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.

Ke W, Sun T, Zhang Y, He L, Wu Q, Liu J, Zha B.

Endocr J. 2017 Jun 29;64(6):581-587. doi: 10.1507/endocrj.EJ16-0547. Epub 2017 Apr 11.

6.

Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy.

Gu X, Zheng L, Chen X, Ruan L, Zhang H, Ge S, Zhu H, Lin X, Shen F.

Horm Metab Res. 2012 Jun;44(6):482-7. doi: 10.1055/s-0032-1308973. Epub 2012 Apr 2.

PMID:
22473756
7.

Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).

Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M.

Neuroimmunomodulation. 2004;11(4):209-13.

PMID:
15249726
8.

[Measurement of IL-12 and IL-18 in sera of patients with autoimmune thyroid disease].

Zhang JA, Zhang J, Xu L, Mar H, Wu XY.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Sep;22(5):630-2. Chinese.

PMID:
16948912
9.

Circulating microRNAs in autoimmune thyroid diseases.

Yamada H, Itoh M, Hiratsuka I, Hashimoto S.

Clin Endocrinol (Oxf). 2014 Aug;81(2):276-81. doi: 10.1111/cen.12432. Epub 2014 Mar 19.

PMID:
24533739
10.

Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.

Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L, Tonacchera M, Bellastella A, Serio M.

Am J Pathol. 2002 Jul;161(1):195-206.

11.

Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.

Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M.

Clin Endocrinol (Oxf). 2006 Feb;64(2):189-95.

PMID:
16430719
12.

Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.

Myśliwiec J, Okota M, Nikołajuk A, Górska M.

Adv Med Sci. 2006;51:119-22.

PMID:
17357290
13.

Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process.

Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Romagnani P, Grosso M, Ferrannini E, Serio M.

Eur J Endocrinol. 2006 May;154(5):651-8.

PMID:
16645011
14.

Increased differentiation of Th22 cells in Hashimoto's thyroiditis.

Bai X, Sun J, Wang W, Shan Z, Zheng H, Li Y, Zhao Y, Gong M, Teng W.

Endocr J. 2014;61(12):1181-90. doi: 10.1507/endocrj.EJ14-0265. Epub 2014 Sep 20.

15.

Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.

Mysliwiec J, Oklota M, Nikolajuk A, Waligorski D, Gorska M.

Immunol Invest. 2007;36(3):247-57.

PMID:
17558708
16.

Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.

Iitaka M, Miura S, Yamanaka K, Kawasaki S, Kitahama S, Kawakami Y, Kakinuma S, Oosuga I, Wada S, Katayama S.

J Clin Endocrinol Metab. 1998 Nov;83(11):3908-12.

PMID:
9814467
17.

Elevated interleukin-1β in peripheral blood mononuclear cells contributes to the pathogenesis of autoimmune thyroid diseases, especially of Hashimoto thyroiditis.

Sun L, Zhang X, Dai F, Shen J, Ren C, Zuo C, Zhang Q.

Endocr Res. 2016 Aug;41(3):185-92. doi: 10.3109/07435800.2015.1124439. Epub 2016 Feb 11.

PMID:
26864865
18.

Lower Serum 25-Hydroxyvitamin D Level is Associated With 3 Types of Autoimmune Thyroid Diseases.

Ma J, Wu D, Li C, Fan C, Chao N, Liu J, Li Y, Wang R, Miao W, Guan H, Shan Z, Teng W.

Medicine (Baltimore). 2015 Sep;94(39):e1639. doi: 10.1097/MD.0000000000001639.

19.
20.

Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.

Federige MAF, Romaldini JH, Miklos ABPP, Koike MK, Takei K, Portes ES.

Arch Endocrinol Metab. 2017 Dec;61(6):600-607. doi: 10.1590/2359-3997000000309.

Supplemental Content

Support Center